Sabra Healthcare REIT Inc (SBRA) posted a 3.66% change over the last five days signaling a new trend

On Friday, Sabra Healthcare REIT Inc (NASDAQ: SBRA) was 2.52% up from the session before settling in for the closing price of $18.22. A 52-week range for SBRA has been $12.83 – $19.32.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Real Estate Sector giant was 1.01%. When this article was written, the company’s average yearly earnings per share was at 791.34%. With a float of $230.43 million, this company’s outstanding shares have now reached $231.27 million.

Let’s determine the extent of company efficiency that accounts for 48 employees. In terms of profitability, gross margin is 50.51%, operating margin of 51.58%, and the pretax margin is 8.0%.

Sabra Healthcare REIT Inc (SBRA) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Sabra Healthcare REIT Inc stocks. The insider ownership of Sabra Healthcare REIT Inc is 1.64%, while institutional ownership is 92.05%. The most recent insider transaction that took place on May 22 ’24, was worth 101,010. In this transaction Director of this company bought 7,000 shares at a rate of $14.43, taking the stock ownership to the 46,385 shares. Before that another transaction happened on May 14 ’24, when Company’s Director sold 10,000 for $14.68, making the entire transaction worth $146,830. This insider now owns 63,923 shares in total.

Sabra Healthcare REIT Inc (SBRA) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 791.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 68.42% during the next five years compared to -47.68% drop over the previous five years of trading.

Sabra Healthcare REIT Inc (NASDAQ: SBRA) Trading Performance Indicators

You can see what Sabra Healthcare REIT Inc (SBRA) is doing with its current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.45. Likewise, its price to free cash flow for the trailing twelve months is 14.84.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.22, a number that is poised to hit 0.16 in the next quarter and is forecasted to reach 0.68 in one year’s time.

Technical Analysis of Sabra Healthcare REIT Inc (SBRA)

Looking closely at Sabra Healthcare REIT Inc (NASDAQ: SBRA), its last 5-days average volume was 1.26 million, which is a drop from its year-to-date volume of 2.02 million. As of the previous 9 days, the stock’s Stochastic %D was 81.05%. Additionally, its Average True Range was 0.37.

During the past 100 days, Sabra Healthcare REIT Inc’s (SBRA) raw stochastic average was set at 88.26%, which indicates a significant increase from 86.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 19.70% in the past 14 days, which was lower than the 21.45% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $17.66, while its 200-day Moving Average is $15.25. However, in the short run, Sabra Healthcare REIT Inc’s stock first resistance to watch stands at $18.92. Second resistance stands at $19.17. The third major resistance level sits at $19.50. If the price goes on to break the first support level at $18.34, it is likely to go to the next support level at $18.01. Now, if the price goes above the second support level, the third support stands at $17.76.

Sabra Healthcare REIT Inc (NASDAQ: SBRA) Key Stats

There are 231,496K outstanding shares of the company, which has a market capitalization of 4.38 billion. As of now, sales total 647,510 K while income totals 13,760 K. Its latest quarter income was 176,140 K while its last quarter net income were 23,980 K.